Cindy Tahl - 03 Jan 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
General Counsel and Secretary
Signature
/s/ Cindy Tahl
Issuer symbol
FATE
Transactions as of
03 Jan 2022
Net transactions value
-$2,639,353
Form type
4
Filing time
04 Jan 2022, 15:03:21 UTC
Previous filing
22 Nov 2021
Next filing
12 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $327,500 +50,000 +30% $6.55 219,006 03 Jan 2022 Direct F1
transaction FATE Common Stock Sale $255,704 -4,427 -2% $57.76* 214,579 03 Jan 2022 Direct F1, F2
transaction FATE Common Stock Sale $994,396 -16,900 -7.9% $58.84* 197,679 03 Jan 2022 Direct F1, F3
transaction FATE Common Stock Sale $1,664,826 -27,812 -14% $59.86* 169,867 03 Jan 2022 Direct F1, F4
transaction FATE Common Stock Sale $51,927 -861 -0.51% $60.31* 169,006 03 Jan 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -50,000 -43% $0.000000 66,643 03 Jan 2022 Common Stock 50,000 $6.55 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021.
F2 Represents the weighted average sale price of the shares sold ranging from $57.26 to $58.18 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 5.
F3 Represents the weighted average sale price of the shares sold ranging from $58.26 to $59.25 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $59.30 to $60.29 per share.
F5 Represents the weighted average sale price of the shares sold ranging from $60.30 to $60.33 per share.
F6 This option is fully vested.